We have further collaborated with colleagues across many disciplines and institutions, including Public Health England, University College London, London School of Hygiene and Tropical Medicine, University of Birmingham, King’s College London, Brighton and Sussex Medical School, University of Liverpool, Imperial College London, the Amsterdam Institute of Global Health and many others.
We used award data from all the major national and international funders, including the Wellcome Trust, Medical Research Council, National Institute for Health Research and Department of Health, European Commission and the Bill and Melinda Gates Foundation.
Beyond the numerous peer-reviewed publications, our analysis has been used by a wide variety of other groups and individuals. Here we list a selection of the known outputs that have been informed by ResIn:
- World Health Organisation R&D Observatory – ResIn has informed their activity, and had a paper considering investment and published outputs published as part of their call for evidence.
- Secretariat of the UK Collaborative on Development Science (using ResIn data to support their working papers/approach/outputs). For example, ResIn critiqued a draft of their capacity-strengthening report, and are cited in the final version.
- Advisor to internal analyses at the Wellcome Trust relating to their research portfolio on vaccines research, this then informed their new strategy
- Cited in Department of Maternal, Newborn, Child and Adolescent Health progress report 2014-2015
- Academy of Medical Sciences consultation on multiple morbidities (ResIn presented evidence on research investment and methodology and contributed to the initial report and findings)
- All Parliamentary Work Group consultation on UK academic contribution to global health (Resin are cited twice in the final report)
- All Parliamentary Working Group consultation on TB research
- MRC discussions regarding funding portfolio for mycology research
- Contributed to roundtable discussions and cited in the 2016 report by the Foundation for Science and Technology on ‘How should universities and Research Councils proactively respond to gender bias in success rates in grant applications?’
- MRC-led mapping exercise for AMR research in UK and Europe (later resulting in this publication and associated comment by ResIn authors Joseph Fitchett and Rifat Atun)
- Data used as part of the evidence base in the Global Action Fund for Fungal Infections (GAFFI) Roadmap
- Department of Health and Infectious Disease Research Network pandemic influenza research working group
- Department of Health and Infectious Disease Research Network Pseudomonas control and research working group
- Department of Health and Infectious Disease Research Network antibiotic prescribing research working group
- House of Lords HIV consultation
- Parliamentary Select Committee on Antimicrobial Resistance
- National Institute for Health Research antimicrobial resistance research strategy
- Discussions with the National Institute for Health Research (Health Technology Assessment) to inform their priority-setting exercises
- BBSRC strategy regarding antimicrobial resistance
- ARHAI strategy and other DH expert advisory groups
- University Global Health Impact Report Card project, by Medsin and the Universities Allied for Essential Medicines group.
- UCL town hall meeting and institutional strategy on antimicrobial resistance
- Cited in several grant applications as part of the researcher’s justification (e.g. x2 successful large awards from Wellcome for translational mycology research)
- Stimulus for a research workshop to discuss norovirus research priorities
- Informed Athena Swann strategy through UCL and London School of Hygiene and Tropical Medicine, plus the Springboard initiative at University of Southampton